Abstract
Meropenem-vaborbactam resistance in Klebsiella pneumoniae isolates is associated with loss-of-function mutations in the OmpK35 and OmpK36 porins. We identify two previously unknown loss-of-function mutations that confer cefuroxime resistance in K. pneumoniae isolates. The proteins lost were NlpD and KvrA; the latter is a transcriptional repressor that controls capsule production. We demonstrate that KvrA loss reduces OmpK35 and OmpK36 porin production, which confers reduced susceptibility to meropenem-vaborbactam in a KPC-3-producing K. pneumoniae isolate.
Original language | English |
---|---|
Article number | e02208-19 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 64 |
Issue number | 7 |
Early online date | 23 Jun 2020 |
DOIs | |
Publication status | Published - 23 Jun 2020 |